INS and type 2 diabetes mellitus: The short chain fatty acid (SCFA) butyrate is of special interest, with T2D patients reported to harbour fewer butyrate-producing bacteria [34,39] and with butyrate linked to decreased adipocyte inflammation [40] and improved insulin sensitivity [41,42] in mouse models.